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induced Diabetic Rats involved Phosphorylation of GSK3? (Ser-9) in Liver. 
 
Abstract 
 
Gynura procumbens, a medicinal plant locally known as Sambung nyawa, is widely used 
traditionally in South East Asia as a remedy to alleviate symptoms of various ailments 
including diabetes mellitus. Previous investigators reported that the ethanol plant extract 
was hypoglycemic in streptozotocin (STZ)-induced diabetic rats and suggested the blood 
glucose-reducing effect could be due to G. procumbens mimicking insulin effects. Our 
present study aimed to reevaluate the hypoglycemic effect(s) of G. procumbens and to 
ascertain the involvement of glycogen synthase kinase (GSK3), a key component of 
insulin biosignaling in the plant activity. A cell-based assay showed that the three G. 
procumbens fractions tested did not exhibit anti-GSK3 activities. Oral administrations of 
hexane, ethyl acetate, n-butanol fractions of G. procumbens (250 mg/kg b.w.) and 
Glibenclamide (5 mg/kg b.w.) for 14 days in STZ-induced diabetic rats reduced blood 
glucose levels by 29.7%, 60.1%, 33.5% and 61.7% (p<0.05), respectively compared to 
diabetic control. Liver glycogen contents were elevated (p<0.05), following 
administration of the three fractions of G. procumbens in diabetic rats when analysed 
after 14 days of treatment. Western blot analysis also showed GSK3β in the liver of G. 
procumbens fractions-treated and Glibenclamide-treated animals were phosphorylated at 
Ser-9. The above findings indicated that the hypoglycemic action of G. procumbens 
fractions resulted in the inactivation of GSK3β in liver of diabetic rats. Since G. 
procumbens fractions did not exhibit GSK3 inhibitory properties, it is possible that the 
hypoglycemic action of the fractions observed here could be due to direct or indirect 
effects on upstream components of the insulin biosignaling pathway. 
 
 
